These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37814964)

  • 1. Safety and protection of plasma donors: A scoping review and evidence gap map.
    Schroyens N; D'aes T; De Buck E; Mikkelsen S; Tiberghien P; van den Hurk K; Erikstrup C; Compernolle V; Van Remoortel H
    Vox Sang; 2024 Feb; 119(2):110-120. PubMed ID: 37814964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective multicentre study on the safety of long-term intensive plasmapheresis in donors (SIPLA).
    Schulzki T; Seidel K; Storch H; Karges H; Kiessig S; Schneider S; Taborski U; Wolter K; Steppat D; Behm E; Zeisner M; Hellstern P;
    Vox Sang; 2006 Aug; 91(2):162-73. PubMed ID: 16907878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor safety in an individualized plasmapheresis program - Results of an interim analysis.
    Taborski U; Laitinen T
    Transfus Apher Sci; 2022 Oct; 61(5):103446. PubMed ID: 35461780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Offering new and returned donors the option to give plasma: implications for donor retention and donor adverse events.
    Thijsen A; Davison TE; Speedy J; Hoad V; Masser B
    Vox Sang; 2021 Mar; 116(3):273-280. PubMed ID: 32702163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of donation frequency on donor health in blood donors donating plasma by plasmapheresis: study protocol for a randomized controlled trial.
    Haugen M; Magnussen K; Aarsland TE; Nissen-Meyer LSH; Strand TA
    Trials; 2024 Mar; 25(1):175. PubMed ID: 38468338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor vigilance data of a blood transfusion service: A multicenter analysis.
    Burkhardt T; Dimanski B; Karl R; Sievert U; Karl A; Hübler C; Tonn T; Sopvinik I; Ertl H; Moog R
    Transfus Apher Sci; 2015 Oct; 53(2):180-4. PubMed ID: 26074050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risks of low hemoglobin deferral in a large retrospective cohort of plasmapheresis donors and the influence factors of return for a subsequent donation in China.
    Xiao G; Dong D; Wang Y; Li C; Huang GT; Yang H; Huang J; Chen F
    PeerJ; 2023; 11():e14999. PubMed ID: 36935911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel approach to increasing inventory with the current panel: increasing donation frequency by asking for a different blood product.
    Bagot KL; Masser BM; White KM
    Transfusion; 2015 Jun; 55(6):1294-302. PubMed ID: 25652648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Plasma Unit Weight and Donor Sex on Post-Donation Citrate Level: An Experimental Study on Plasmapheresis Donors.
    Marraccini C; Schiroli D; Mancuso P; Molinari G; Razzoli A; Gavioli G; Fasano T; Baricchi R; Rossi PG; Merolle L
    Transfus Med Hemother; 2023 Dec; 50(6):491-501. PubMed ID: 38089491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Source Plasma Donation: The Experience of the Iranian Blood Transfusion Organization.
    Mohammadi S; Aghabozorg F; Balagholi S; Ferdowsi S; Sharifi S; Eshghi P
    Int J Hematol Oncol Stem Cell Res; 2022 Jul; 16(3):151-156. PubMed ID: 36694705
    [No Abstract]   [Full Text] [Related]  

  • 12. Personalized collection of plasma from healthy donors: A randomized controlled trial of a novel technology-enabled nomogram.
    Hartmann J; Ragusa MJ; Burchardt ER; Manukyan Z; Popovsky MA; Leitman SF
    Transfusion; 2021 Jun; 61(6):1789-1798. PubMed ID: 33760230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance study.
    Cho JH; Rajbhandary S; van Buren NL; Fung MK; Al-Ghafry M; Fridey JL; Dy BA; Ziman A; Schreiber GB; Gammon RR; Reik R; Stubbs JR; van Buskirk CM; Kamel H; Townsend MJ; Zeller MP; Gottschall JL
    Transfusion; 2021 Sep; 61(9):2668-2676. PubMed ID: 34227689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of plasmapheresis on blood pressure in voluntary plasma donors.
    Rosa-Bray M; Wisdom C; Marier JF; Mouksassi MS; Wada S
    Vox Sang; 2015 Jan; 108(1):11-7. PubMed ID: 25169580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of Plasmapheresis in Donors with Low IgG Levels: Results of a Prospective, Controlled Multicentre Study.
    Moog R; Laitinen T; Taborski U
    Transfus Med Hemother; 2022 Sep; 49(5):271-279. PubMed ID: 37969863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor tolerability of convalescent plasma donation.
    He R; Lin H; Xie S; Lv Q; Kong Y; Li L; Xu H; Wang J; Li W; Fang P; Wu Y; Liu Z
    J Clin Apher; 2021 Jun; 36(3):429-436. PubMed ID: 33587767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective study assessing the characteristics of COVID-19 convalescent plasma donors and donations.
    Del Fante C; Franchini M; Baldanti F; Percivalle E; Glingani C; Marano G; Mengoli C; Mortellaro C; Viarengo G; Perotti C; Liumbruno GM
    Transfusion; 2021 Mar; 61(3):830-838. PubMed ID: 33231325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Building a flexible, voluntary donation panel: an exploration of donor willingness.
    Bagot KL; Masser BM; Starfelt LC; White KM
    Transfusion; 2016 Jan; 56(1):186-94. PubMed ID: 26408074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Demography and donation frequencies of blood and plasma donor populations in Germany. Update 2010 and 5-year comparison].
    Ritter S; Hamouda O; Offergeld R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Aug; 55(8):914-22. PubMed ID: 22842884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions that address institutional child maltreatment: An evidence and gap map.
    Finch M; Featherston R; Chakraborty S; Bjørndal L; Mildon R; Albers B; Fiennes C; Taylor DJA; Schachtman R; Yang T; Shlonsky A
    Campbell Syst Rev; 2021 Mar; 17(1):e1139. PubMed ID: 37133265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.